期刊文献+

核酶研究概况

下载PDF
导出
作者 朱旋 赵军
出处 《临床泌尿外科杂志》 2003年第10期629-631,共3页 Journal of Clinical Urology
基金 国家自然科学基金资助项目 (No .396 0 0 16 4 )
  • 相关文献

参考文献8

  • 1Irie A. Hammerhead ribozymes as therapeutic agents for bladder cancer. Mol Urol, 2000, 4:61-67.
  • 2Jack J Z. Methods rules for ribozymes Mol Ceiiular Neurocsienxe, 1998, 11:92-96.
  • 3Birikh K R, Berlin Y A, Soreq H. Probing accessible sites for ribozymes on human acetylcholinesterase RNA. RNA, 1997, 3:429-433.
  • 4Lieber A, Strauss M. Selection of efficient cleavage sites in target RNAs by using a ribozyme expression library. Mol Cell Biol, 1995, 15:540-544.
  • 5Li Q X. A novel functional genomics approach identifies mTERT as a supperessor of fibroblast transformation.Nucleic Acids Res, 2000, 28:2605-2609.
  • 6Eastham J A, Ahlering T E. Use of anti-ras ribozyme to alter the malignant phenotype of a human bladder cancer cell line. J Urol, 1996, 156:1186-1189.
  • 7Irie A, Anderegg B, kashani-Sabet M, et al. Therapeutic efficacy of an adenovirus-mediated anti-H-ras ribozyme in experimental bladder cancer. Antisense Nucleic Acid Drug Dev, 1999, 9:341-345.
  • 8Zogakis T G, Libutti S K. General aspects of anti-angiogenesis and cancer therapy. Expert Opin Biol Ther,2001, 1:253-256.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部